Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
27.75
+1.06 (3.97%)
Dec 3, 2025, 4:00 PM EST - Market closed
Legend Biotech Analyst Ratings
Total Analysts
13
Consensus Rating
Strong Buy
Price Target
$72.92
Upside
+162.77%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $94 → $90 | Buy | Maintains | $94 → $90 | +224.32% | Nov 13, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $75 → $74 | Buy | Maintains | $75 → $74 | +166.67% | Nov 13, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $66 → $75 | Buy | Maintains | $66 → $75 | +170.27% | Nov 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $75 → $60 | Strong Buy | Maintains | $75 → $60 | +116.22% | Oct 17, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $78 → $76 | Buy | Maintains | $78 → $76 | +173.87% | Oct 9, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $55 → $66 | Buy | Initiates | $55 → $66 | +137.84% | Aug 27, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $77 → $78 | Buy | Maintains | $77 → $78 | +181.08% | Aug 25, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $75 → $77 | Buy | Maintains | $75 → $77 | +177.48% | Aug 12, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $81 → $83 | Buy | Maintains | $81 → $83 | +199.10% | Aug 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +170.27% | Jul 17, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $80 → $81 | Buy | Maintains | $80 → $81 | +191.89% | Jul 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +170.27% | Jul 8, 2025 |
| UBS | UBS | Strong Buy Maintains $60 → $54 | Strong Buy | Maintains | $60 → $54 | +94.59% | Jul 2, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $88 → $71 | Strong Buy | Maintains | $88 → $71 | +155.86% | May 14, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $55 | Buy | Reiterates | $55 | +98.20% | May 14, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $84 | Buy | Reiterates | $84 | +202.70% | Apr 22, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.